
An experimental prostate cancer drug from Medivation Inc helped patients live longer in a late-stage study, sending the company's shares soaring on hopes that it will become a strong contender in an estimated $9 billion market. ... New Drug Improves Prostate Cancer Survival
No comments:
Post a Comment